113 related articles for article (PubMed ID: 28889389)
21. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
22. Urine RNA Processing in a Clinical Setting: Comparison of 3 Protocols.
Bradley MS; Boudreau MH; Grenier C; Huang Z; Murphy SK; Siddiqui NY
Female Pelvic Med Reconstr Surg; 2019; 25(3):247-251. PubMed ID: 29194081
[TBL] [Abstract][Full Text] [Related]
23. Extraction of urinary cell-free DNA by using triamine-modified silica particles for liquid biopsy.
Kato M; Fujita Y; Iizuka T; Nozaki K; Takano S; Funatsu T; Sano Y; Murayama S; Karasawa K
Anal Bioanal Chem; 2020 Sep; 412(23):5647-5652. PubMed ID: 32613569
[TBL] [Abstract][Full Text] [Related]
24. Assessment of Urinary MicroRNAs by Quantitative Polymerase Chain Reaction in Diabetic Nephropathy Patients.
Newbury LJ; Wonnacott A; Simpson K; Bowen T; Fraser D
Methods Mol Biol; 2020; 2067():277-285. PubMed ID: 31701457
[TBL] [Abstract][Full Text] [Related]
25. Real time reverse transcriptase polymerase chain reaction of urinary cytokeratin 20 detects transitional cell carcinoma cells.
Inoue T; Nakanishi H; Inada K; Hioki T; Tatematsu M; Sugimura Y
J Urol; 2001 Dec; 166(6):2134-41. PubMed ID: 11696722
[TBL] [Abstract][Full Text] [Related]
26. Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay.
Eissa S; Matboli M; Essawy NO; Shehta M; Kotb YM
Biomarkers; 2015; 20(3):212-7. PubMed ID: 26161701
[TBL] [Abstract][Full Text] [Related]
27. Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma.
Fedorko M; Juracek J; Stanik M; Svoboda M; Poprach A; Buchler T; Pacik D; Dolezel J; Slaby O
Biochem Med (Zagreb); 2017 Jun; 27(2):411-417. PubMed ID: 28694731
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence in situ hybridization status of voided urine predicts invasive and high-grade upper tract urothelial carcinoma.
Su X; Hao H; Li X; He Z; Gong K; Zhang C; Cai L; Zhang Q; Yao L; Ding Y; Gong Y; Fang D; Zhang Z; Zhou L
Oncotarget; 2017 Apr; 8(16):26106-26111. PubMed ID: 28212539
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.
Schmidt J; Propping C; Siow WY; Lohse-Fischer A; Toma M; Baldauf-Twelker A; Hakenberg OW; Wirth MP; Fuessel S
J Cancer Res Clin Oncol; 2016 Feb; 142(2):401-14. PubMed ID: 26328914
[TBL] [Abstract][Full Text] [Related]
30. Nested quantitative PCR approach for urinary cell-free EZH2 mRNA and its potential clinical application in bladder cancer.
Zhang X; Zhang Y; Liu X; Liu T; Li P; Du L; Yang Y; Wang L; Wang C
Int J Cancer; 2016 Oct; 139(8):1830-8. PubMed ID: 27300769
[TBL] [Abstract][Full Text] [Related]
31. Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma.
Li G; Zhao A; Péoch M; Cottier M; Mottet N
Urol Oncol; 2017 May; 35(5):294-299. PubMed ID: 28089386
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of bladder cancer using telomerase activity in voided urine.
Cheng CW; Chueh SC; Chern HD
J Formos Med Assoc; 2000 Dec; 99(12):920-5. PubMed ID: 11155745
[TBL] [Abstract][Full Text] [Related]
33. [Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma].
Yokota K; Kanayama H; Kagawa S; Abe-Hashimoto J; Hirose M; Yoshimura T
Nihon Rinsho; 1998 May; 56(5):1292-8. PubMed ID: 9613140
[TBL] [Abstract][Full Text] [Related]
34. Analytical Comparison of Methods for Extraction of Short Cell-Free DNA from Urine.
Oreskovic A; Brault ND; Panpradist N; Lai JJ; Lutz BR
J Mol Diagn; 2019 Nov; 21(6):1067-1078. PubMed ID: 31442674
[TBL] [Abstract][Full Text] [Related]
35. DNA Methylation Analysis from Body Fluids.
Dietrich D
Methods Mol Biol; 2018; 1655():239-249. PubMed ID: 28889390
[TBL] [Abstract][Full Text] [Related]
36. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.
Weikert S; Krause H; Wolff I; Christoph F; Schrader M; Emrich T; Miller K; Müller M
Int J Cancer; 2005 Nov; 117(2):274-80. PubMed ID: 15900578
[TBL] [Abstract][Full Text] [Related]
37. RNA Amplification Protocol Leads to Biased Polymerase Chain Reaction Results Especially for Low-Copy Transcripts of Human Bone Marrow-Derived Stromal Cells.
Coenen C; Liedtke S; Kogler G
PLoS One; 2015; 10(10):e0141070. PubMed ID: 26485654
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
[TBL] [Abstract][Full Text] [Related]
39. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
[TBL] [Abstract][Full Text] [Related]
40. Liquid biopsy? A recent breakthrough in noninvasive bladder cancer surveillance.
Kang M; Ku JH
Investig Clin Urol; 2016 Sep; 57(5):307-8. PubMed ID: 27617310
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
